Hot Reads: Wood’s ARK Takes Bite of Biotech Firm Ginkgo Bioworks

Hot Reads: Wood’s ARK Takes Bite of Biotech Firm Ginkgo Bioworks

Plus, how will retail ETFs respond to big-box stores’ earnings?

lisa
|
Reviewed by: Lisa Barr
,
Edited by: Ron Day

Cathie Wood Buys Millions of Shares of a Struggling Stock (The Street) 

ARK Invest is embracing biotechnology. 

 

What’s in Store for Retail ETFs in Big-Box 1Q Earnings? (Yahoo Finance) 

The sector is expected to report an earnings decline of 0.1% on 5.2% revenue growth. 

 

S&P Barely Budges on Yellen’s Late-Day Notice (Bloomberg) 

Two Fed officials signaled they favored pausing rate hikes. 

 

Regional Banks May Emerge Winners in Debt Showdown: State Street (Bloomberg) 

Debt ceiling deadline could spur unwind of money market trade. 

 

Is Active Outperformance Luck or Skill? (The Evidence Based Investor) 

The latest SPIVA Persistence Scorecard shows again that evidence of genuine repeatable skill is rare. 

 

Commercial Real Estate, Despite Turmoil, Has Bright Spots (Institutional Investor) 

Fundamentals for multifamily housing and industrials remain robust. 

 

Tax-Loss Harvesting During a Downturn (Parametric Portfolio) 

Why not all such opportunities are created equal in a down market. 

Lisa Barr is a former copy editor at etf.com.